OnLume Closes $7M Series A
OnLume Surgical announced recently that it has closed a $7 million Series A financing round. “The completion of the Series A financing, plus the Phase II grant from NCI, provides the…
OnLume Surgical announced recently that it has closed a $7 million Series A financing round. “The completion of the Series A financing, plus the Phase II grant from NCI, provides the…
OnLume has been awarded a $2 million grant from the U.S. National Institutes of Health’s National Cancer Institute to advance the development of its proprietary device for Fluorescence-Guided Surgery (FGS),…
OnLume announced recently that it is beginning a clinical trial for its fluorescence-guided surgery (FGS) imaging device, which will be combined with a novel nerve-targeting agent. The Phase I-II study, which…
The Greater Madison Chamber of Commerce today announced the five finalists for its annual Pressure Chamber pitch contest, to be held at 2:30 p.m., Tuesday, Aug. 27 at the Overture…
OnLume, a medical device company developing surgical lighting technology, is the recipient of a Phase I SBIR grant through the National Cancer Institute SBIR worth $300,000. “At OnLume, we believe…